| Ytd | 9.77% | |
| 1y | 27.85% |
| Open | 5.27 | Prev Close | 5.27 | Low | 5.22 | High | 5.39 | Mkt Cap | 456.86M |
| Vol | 1.19M | Avg Vol | 1.07M | EPS | -0.19 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 5.52 | 200-d Avg | 4.99 | 1yr Est | 0.00 |
SRTA News
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today annou
Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company"))), today anno
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $260.000 million-$275.000 mi
Strata Critical Medical (NASDAQ:SRTA) reported quarterly earnings of $0.03 per share which beat the
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today annou
Ark Invest made no trades in its six main ETFs for two straight days, a rare feat. Here's how th
Craig-Hallum analyst Bill Bonello initiates coverage on Strata Critical Medical (NASDAQ:SRTA) wit
B. Riley Securities analyst Yuan Zhi initiates coverage on Strata Critical Medical (NASDAQ:SRTA)
Dow falls over 1,100 points as shares of Ingram Micro jump 11.8% on better-than-expected earnings. O
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $255.000 million-$270.000 mil
Strata Critical Medical (NASDAQ:SRTA) reported quarterly sales of $66.787 million which beat the ana
Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), a leading p
